Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:NCNO
NasdaqGS:NCNOSoftware

nCino (NCNO) Is Up 20.4% After Return To Profitability And Buyback Completion - What's Changed

In late March 2026, nCino, Inc. reported fourth-quarter and full-year results showing higher revenue and a move from a net loss to net income, alongside new guidance for fiscal 2027 and completion of a US$25,000,000 share repurchase covering 967,571 shares. The company also filed a US$98.55 million employee share offering shelf, appointed experienced revenue leader Keith Kettell as Chief Revenue Officer, and continued to win new banking clients such as Luana Savings Bank to modernize lending...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Valuation Check After Advertising Ruling And Rising Legal Scrutiny

Regulatory spotlight on Freshpet after advertising ruling The recent move in Freshpet (FRPT) was sparked by a National Advertising Division ruling that its dog food ads should drop or revise "human grade" claims, followed by securities law investigations and a sharp share price reaction. See our latest analysis for Freshpet. Beyond the immediate reaction to the advertising ruling and legal investigations, Freshpet’s 1 month share price return of 28.59% decline and 1 year total shareholder...
NYSE:CYD
NYSE:CYDMachinery

China Yuchai International (CYD) Is Up 8.1% After 40% EPS Upgrade Has The Bull Case Changed?

Recently, analysts raised their full-year earnings projections for China Yuchai International by 40.5%, while the company’s year-to-date return has outpaced both the broader Auto-Tires-Trucks sector and its Automotive - Original Equipment peers. This combination of sharply upgraded earnings expectations and clear relative performance strength suggests analysts and investors are reassessing the company’s profit and competitive outlook. We’ll now explore how this upgrade in earnings...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Valuation Check After EVOQUE TRISCEND II Results And Growing Regulatory Momentum

Edwards Lifesciences (EW) put fresh clinical data for its EVOQUE tricuspid valve system in the spotlight at the ACC.26 conference, highlighting sustained patient benefits and lower mortality in the TRISCEND II trial. See our latest analysis for Edwards Lifesciences. At a share price of $81.19, Edwards Lifesciences has seen a 17.67% 1 year total shareholder return. The 90 day share price return of a 5.43% decline suggests recent momentum has cooled despite supportive EVOQUE trial headlines. If...
NYSE:CSL
NYSE:CSLBuilding

Assessing Carlisle Companies (CSL) Valuation After Recent Share Price Moves

Why Carlisle Companies is on investors’ radar today Carlisle Companies (CSL) is drawing attention after recent share price moves, with the stock showing a mix of modest gains over the past week alongside weaker performance over the past month and past 3 months. Those shifts are prompting closer scrutiny of its US$13.5b market value, current price near US$331, and broader context as a building envelope products manufacturer with operations across the United States, Europe and other...
NYSE:TKR
NYSE:TKRMachinery

Assessing Timken (TKR) Valuation After Strong One Year Returns And Mixed Recent Share Moves

Timken: key performance markers investors are watching Timken (TKR) has drawn fresh attention after recent share moves, with the stock showing mixed returns over the past week, month and past 3 months while longer term performance and profitability metrics present a different picture. See our latest analysis for Timken. At a share price of $98.94, Timken’s recent 7 day share price return of 3.13% contrasts with a modest 30 day share price pullback, while the 1 year total shareholder return of...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

A Look At Scholar Rock (SRRK) Valuation After Apitegromab BLA Resubmission And Reduced Regulatory Risk

Scholar Rock Holding (SRRK) has resubmitted its Biologics License Application for apitegromab to the FDA, following alignment with regulators on facility remediation and the addition of a second US based fill finish site. See our latest analysis for Scholar Rock Holding. The BLA resubmission appears to have kept attention on Scholar Rock, with a 7 day share price return of 13.3% and an 18.16% 90 day share price return. The 1 year total shareholder return of 87.44% points to strong momentum...
NYSE:ORA
NYSE:ORARenewable Energy

Should Ormat’s 149 MW Geothermal and Storage Expansion Plans Require Action From Ormat Technologies (ORA) Investors?

In recent months, Ormat Technologies has outlined plans to add 149 MW of new capacity by the end of 2027, including 101 MW from geothermal projects, while committing US$180 million to build additional energy storage assets in the United States through 2028. This combination of geothermal expansion and sizable storage investment highlights Ormat’s effort to deepen its role in supplying grid-stable renewable power as adoption of clean energy accelerates. Next, we’ll explore how Ormat’s planned...
TSE:8331
TSE:8331Banks

Chiba Bank (TSE:8331) Valuation Check After New Buyback Plan And Holding Company Proposal

What the new buyback and holding company plan mean for Chiba Bank (TSE:8331) investors Chiba Bank (TSE:8331) has drawn fresh attention after its board approved a new share repurchase program alongside plans to form Chiba Financial Group, Inc. as a holding company, subject to regulatory and shareholder approvals. The bank intends to buy back up to 10,000,000 shares, or 1.43% of its issued share capital, for up to ¥15,000 million by June 30, 2026, with the stated aim of improving capital...
NYSE:CNA
NYSE:CNAInsurance

Assessing CNA Financial (CNA) Valuation After Earnings Miss And Higher Dividend

Why CNA Financial (CNA) Is Back in Focus After Its Latest Quarter CNA Financial (CNA) has drawn fresh attention after quarterly results came in below market expectations, with weaker core earnings per share and profitability despite growth in premiums and investment income. At the same time, management raised the regular dividend by 4% and announced a special dividend. This move highlights confidence in ongoing cash generation, even as underwriting performance and higher expenses remain key...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Why Meta Platforms (META) Is Up 6.8% After Landmark Addictive‑Design Liability Verdicts Against Its Apps

In recent weeks, Meta Platforms has faced major legal setbacks as US juries in California and New Mexico found its social media products liable for addictive design harms to minors, resulting in multimillion‑dollar penalties and fresh scrutiny of its platform practices. These rulings mark one of the first times a large social network has been treated as a potentially defective product under US product liability law, opening the door to broader challenges against how Meta engineers engagement...
TASE:LUZC
TASE:LUZCHospitality

Middle Eastern Penny Stocks To Watch: 3 Picks With Market Caps Under US$900M

Gulf stock markets have shown mixed performances recently, with investors closely watching geopolitical developments, particularly the US-Iran talks. For those exploring beyond well-known names, penny stocks—typically smaller or newer companies—can present intriguing opportunities. While the term may seem outdated, these stocks remain relevant as they often combine value and growth potential that larger firms might lack.
TASE:ARYT
TASE:ARYTAerospace & Defense

Undiscovered Gems In The Middle East To Explore This April 2026

As Gulf equities show mixed performances amid geopolitical tensions and cautious investor sentiment, the Middle East market presents a unique landscape for those exploring opportunities in lesser-known stocks. In this environment, identifying promising companies often involves looking beyond immediate market fluctuations to focus on robust fundamentals and strategic positioning that can weather uncertainty.
TASE:MTRX
TASE:MTRXIT

Middle Eastern Dividend Stocks Featuring Top 3 Picks

In the midst of geopolitical uncertainty and mixed performances across Gulf markets, investors in the Middle East are closely monitoring developments such as US-Iran talks that could impact regional stability and economic conditions. Amidst these fluctuations, dividend stocks remain an attractive option for those seeking steady income streams, especially given their potential to provide resilience in volatile markets.